[China Traditional Chinese Medicine (00570) released interim results, with a loss of 776 million yuan attributable to shareholders 619% year-on-year expansion] On August 28, China Traditional Chinese Medicine (00570) released its interim results for the six months ended June 30, 2026, with a revenue of 5.438 billion yuan, a year-on-year decrease of 27.1%; a loss attributable to shareholders of 776 million yuan, a year-on-year increase of 619.3%; and a basic loss per share of 15.42 cents. The announcement stated that during the reporting period, the group's operating income fell by 27.1% year-on-year, mainly because the traditional Chinese medicine formula granule business was affected by industry policy adjustments and changes in the market environment, resulting in a decline in terminal demand and a decrease in sales volume in this period.